Objective: Paclitaxel (P) is a standard second-line chemotherapy in the treatment of
advanced gastric cancer. This study compared the clinical outcome of a paclitaxel plus …

Background Paclitaxel is a microtubule stabilizing agent, used as standard second line
chemotherapy in the treatment of advanced gastric cancer. This study was designed to …

Background Weekly paclitaxel (wPTX) is the preferred second-line chemotherapy for gastric
cancer in Japan. Histone deacetylase inhibitors have been shown to decrease proliferation …

The aim of this study was to evaluate the efficacy and safety of paclitaxel-based regimens as
first-line treatments in advanced gastric cancer. We reviewed 397 previously untreated …

Purpose To evaluate the therapeutic activity and safety of paclitaxel and cisplatin
combination chemotherapy in patients with advanced or metastatic gastric cancers that are …

Background Although many treatments for advanced gastric cancer have been developed,
only poor treatment results have generally been obtained. We performed a prospective …

The standard regimen of second-line chemotherapy for patients with unresectable gastric
cancer has not been established. However, weekly paclitaxel (wPTX) has become the …

Methods: We searched systematically for studies from the databases of PubMed, Embase,
Web of Science and the Cochrane Library published between January 2000 and August …

4 Background: There is a need for effective treatments in the second-or further line setting in
advanced gastric cancer, especially for new agents. In the current trial we evaluated …

Background: A combination of S-1 and cisplatin has been shown to be effective with
acceptable safety for the first-line treatment of far-advanced gastric cancer in Japan. This is …